BearingPoint study: Powered by the people! Successful organizations are built on a resilient workforce
21.7.2022 09:03:00 EEST | Business Wire | Press release
Management and technology consultancy BearingPoint has created a deep-dive study on enabling people to manage and embrace change to drive organizational success. “Powered by the people,” the second of five companion pieces to the 2021 “Can you thrive under pressure” study, analyzed over 5,000 projects to rank 150 leading resilient organizations. BearingPoint has also created a resilience benchmarking tool that enables any organization to assess its alignment with the five fundamental pillars of resilience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220720005745/en/
BearingPoint study: Successful organizations are built on a resilient workforce. (Graphic: Business Wire)
BearingPoint’s proprietary benchmarking tool shows that most organizations understand that success is based on empowering their people for change. Yet only 60% of organizations considered their people to be fully resilient. However, the study also concludes that even these organizations cannot afford to be complacent.
BearingPoint’s study found that an organization’s people-related strategy is vital to its overall success. Many organizations recognize that they can do more to create an environment for their people to be successful. For example, there is a clear correlation between manager autonomy and the success of transformation projects. Yet frontline manager autonomy is still low (22% in France, 19% in Germany and 30% in the United Kingdom), with communication cited as a key gap. 55% want more information during a project, 45% want clearer guidelines and desire to collaborate more, and 39% want access to specific expertise while implementing change projects. The study shows that best practice links your people to a clear purpose and vision, providing agile working models with the flexibility to respond and structured around multi-skilled teams empowered to make decisions.
BearingPoint’s research proves that an organization’s people strategy can only be successful if it is underpinned by the five dimensions of a resilient organization:
- Empower people for change: Resilient companies support their people to adapt to change and uncertainty rapidly.
- Understand the customer ecosystem: Resilient companies enable their people to understand their customers and supply chain; and they make sure their people interact positively with customers, suppliers and other stakeholders.
- Align data centricity with business outcomes: People interconnected to data and data owned by the people ought to be an integral part of understanding the role of data in supporting business decisions.
- Use technology to improve agility: Resilient companies use technology to enable people to be productive and involved.
- Build effective governance for smart decisions: Resilient companies introduce people governance for better decision-making with appropriate structures, clear decision-making processes and effective escalations.
Andrew Montgomery, Global Leader Government and Public Sector at BearingPoint, notes: “Our insights support the view that organizations which have been the most successful in retaining, developing and managing their workforce during and post-pandemic are those that have recognized the importance of resilience as a core characteristic in its people. Their workforce strategies include specific outcomes related to creating an environment where people can develop, be supported and be empowered to become more resilient. And the indicators are that investment in these areas can lead to tangible results in terms of retention, employee wellbeing and performance.”
All the categories of organizations that BearingPoint studied showed that empowering their people for change was a key element of their strategy. However, people strategies lagged behind customer strategies. There were also variations across sectors, with government organizations having lower people resilience scores than other sectors. According to the study, leading private sector companies have responded to reoccurring crises by investing more in their people and therefore have benefited from increased company resilience.
Claudia Carr, Partner at BearingPoint, says: “There are many factors which support the development of resilience within your workforce. It starts with culture and is enhanced through learning and collaboration. Resilient organizations recognize the importance of soft skills, starting from hiring and as part of continuous development programs. The ability to manage change, communicate, collaborate and problem solve are all critical skills when navigating change. We see resilient organizations as those supporting the development of these skills, not only with their leaders but throughout the organization.”
About the study
BearingPoint analyzed over 5,000 client projects, built a model to assess how organizations create successful long-term transformations, and then calibrated resilience profiles based on five observed characteristics.
To find out more, you can download the study here: https://www.bearingpoint.com/en/insights-events/insights/successful-organisations-are-built-on-a-resilient-workforce/
About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.
BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 13,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.
For more information, please visit:
Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220720005745/en/
Contact information
Press contact
Alexander Bock
Global Manager Communications
Telephone: +49 89 540338029
E-Mail: alexander.bock@bearingpoint.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release
Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release
Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release
Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
